BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14507364)

  • 1. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region.
    Zhang N; Torrelles JB; McNeil MR; Escuyer VE; Khoo KH; Brennan PJ; Chatterjee D
    Mol Microbiol; 2003 Oct; 50(1):69-76. PubMed ID: 14507364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan.
    Escuyer VE; Lety MA; Torrelles JB; Khoo KH; Tang JB; Rithner CD; Frehel C; McNeil MR; Brennan PJ; Chatterjee D
    J Biol Chem; 2001 Dec; 276(52):48854-62. PubMed ID: 11677227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan.
    Shi L; Berg S; Lee A; Spencer JS; Zhang J; Vissa V; McNeil MR; Khoo KH; Chatterjee D
    J Biol Chem; 2006 Jul; 281(28):19512-26. PubMed ID: 16687411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan.
    Berg S; Starbuck J; Torrelles JB; Vissa VD; Crick DC; Chatterjee D; Brennan PJ
    J Biol Chem; 2005 Feb; 280(7):5651-63. PubMed ID: 15546869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability.
    Shi L; Zhou R; Liu Z; Lowary TL; Seeberger PH; Stocker BL; Crick DC; Khoo KH; Chatterjee D
    J Bacteriol; 2008 Aug; 190(15):5248-55. PubMed ID: 18556798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small multidrug resistance-like transporter involved in the arabinosylation of arabinogalactan and lipoarabinomannan in mycobacteria.
    Larrouy-Maumus G; Škovierová H; Dhouib R; Angala SK; Zuberogoitia S; Pham H; Villela AD; Mikušová K; Noguera A; Gilleron M; Valentínová L; Korduláková J; Brennan PJ; Puzo G; Nigou J; Jackson M
    J Biol Chem; 2012 Nov; 287(47):39933-41. PubMed ID: 23038254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis.
    Goude R; Amin AG; Chatterjee D; Parish T
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4138-46. PubMed ID: 19596878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
    Khoo KH; Douglas E; Azadi P; Inamine JM; Besra GS; Mikusová K; Brennan PJ; Chatterjee D
    J Biol Chem; 1996 Nov; 271(45):28682-90. PubMed ID: 8910503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The singular
    Jankute M; Alderwick LJ; Moorey AR; Joe M; Gurcha SS; Eggeling L; Lowary TL; Dell A; Pang PC; Yang T; Haslam S; Besra GS
    Cell Surf; 2018 Jun; 2():38-53. PubMed ID: 30046665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core.
    Alderwick LJ; Radmacher E; Seidel M; Gande R; Hitchen PG; Morris HR; Dell A; Sahm H; Eggeling L; Besra GS
    J Biol Chem; 2005 Sep; 280(37):32362-71. PubMed ID: 16040600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Mycobacterial AftB Results in Complete Loss of Terminal β(1 → 2) Arabinofuranose Residues of Lipoarabinomannan.
    Jankute M; Alderwick LJ; Noack S; Veerapen N; Nigou J; Besra GS
    ACS Chem Biol; 2017 Jan; 12(1):183-190. PubMed ID: 28033704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.
    Mikusová K; Slayden RA; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2484-9. PubMed ID: 8585730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of embC in Mycobacterium tuberculosis.
    Goude R; Amin AG; Chatterjee D; Parish T
    J Bacteriol; 2008 Jun; 190(12):4335-41. PubMed ID: 18424526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans.
    Kaur D; Lowary TL; Vissa VD; Crick DC; Brennan PJ
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3049-3057. PubMed ID: 12368438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the SucT acyltransferase in
    Palčeková Z; Angala SK; Belardinelli JM; Eskandarian HA; Joe M; Brunton R; Rithner C; Jones V; Nigou J; Lowary TL; Gilleron M; McNeil M; Jackson M
    J Biol Chem; 2019 Jun; 294(26):10325-10335. PubMed ID: 31110045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a distinct arabinofuranosyltransferase in Mycobacterium smegmatis.
    Zhang J; Khoo KH; Wu SW; Chatterjee D
    J Am Chem Soc; 2007 Aug; 129(31):9650-62. PubMed ID: 17630736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single arabinan chain is attached to the phosphatidylinositol mannosyl core of the major immunomodulatory mycobacterial cell envelope glycoconjugate, lipoarabinomannan.
    Kaur D; Angala SK; Wu SW; Khoo KH; Chatterjee D; Brennan PJ; Jackson M; McNeil MR
    J Biol Chem; 2014 Oct; 289(44):30249-30256. PubMed ID: 25231986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the essential arabinosyltransferase EmbC lead to alterations in Mycobacterium tuberculosis lipoarabinomannan.
    Korkegian A; Roberts DM; Blair R; Parish T
    J Biol Chem; 2014 Dec; 289(51):35172-81. PubMed ID: 25352598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed.
    Lee RE; Li W; Chatterjee D; Lee RE
    Glycobiology; 2005 Feb; 15(2):139-51. PubMed ID: 15371346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated lipoglycan from mycobacteria with altered immunological properties.
    Birch HL; Alderwick LJ; Appelmelk BJ; Maaskant J; Bhatt A; Singh A; Nigou J; Eggeling L; Geurtsen J; Besra GS
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2634-9. PubMed ID: 20133807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.